Sentences with phrase «if vaccines»

Writing in The Conversation vaccination experts Kristine Macartney, Julie Leask and Nicholas Wood addressed Ms Hanson's claims around the availability of a test your child can take before getting vaccinated stating that «there is no blood test to see if vaccines shouldn't be given.

If vaccines offered no protection, there would be no reason to give tetanus booster shots to adults after a cut from a rusty blade or a poke from a dirty nail.

As if all vaccines were guaranteed to be safe in all conceivable circumstances.

A team at Purdue University School of Veterinary Medicine conducted several studies1, 2 to determine if vaccines can cause changes in the immune system of dogs that might lead to life - threatening immune - mediated diseases.

A team at Purdue University School of Veterinary Medicine conducted several studies to determine if vaccines can cause changes in the immune system of dogs that might lead to life - threatening immune - mediated diseases.

This will have waned by age 16 weeks leaving the puppy vulnerable if vaccines have not been administered for further protection.

If vaccines have not been administered at University Animal Hospital, you must provide acceptable proof of current vaccination status.

If vaccines can have the same effect in dogs and a dog gets sick because of vaccine - induced mutations in cells in its bone marrow, liver or lungs it will not pass those mutations on to its offspring.

A team at Purdue University School of Veterinary Medicine conducted several studies (1,2) to determine if vaccines can cause changes in the immune system of dogs that might lead to life - threatening immune - mediated

If vaccines are stored in areas that are too warm, or exposed to too much sunlight, they can loose their effectiveness.

If your pet has not been to the veterinarian in the past six months, now is a good time to call and find out if any vaccines will be due during hurricane season.

However, it's best if vaccines are administered to protect the dog.

Because of the early stage of the trials, more work is needed to see «if the vaccines are better than existing treatments, if they improve survival, and what their long - term side effects could be.»

If the vaccines pass these tests then safety trials in humans would be the next step.

But it's too early in clinical development to know if the vaccines will extend the lives of cancer patients.

It remains to be seen what the implications would be for health insurance coverage and public financing of treatments if vaccines or treatments vary by genotype.

But Read says those «hot strains» would die out very quickly if the vaccines were taken away.

While the effect of vaccines was not analyzed as part of this study, Rzhetsky notes that the geographic clustering of autism and ID rates is evidence that if vaccines have a role, it's a very weak one as vaccinations are given uniformly across the US.

Right now, many parents aren't entirely convinced they would be told if vaccines were found to pose risks other than well - known side effects — which makes them fertile territory for the sowers of doubt.

«If you're going to test a new vaccine in a specific place, you should look at the local strains first and see if your vaccines are effective against the local strains people are catching,» he said.

In fact, certain diseases crop up so rarely now that parents sometimes ask if vaccines for them are even necessary.

I feel horrible about not vaxing my kids even if the vaccines did cause autism, I would rather see my children autistic than dead or in severe pain and trauma from something that could have been prevented.

It's unclear if the vaccine, rVSV - ZEBOV, will actually be used in this particular instance — but public health officials are preparing for the need should the DRC request it.

Two weeks after the final vaccine was administered, the mice were analysed to see if the vaccine protected the mice.

Researchers are trying to find out if a vaccine against meningitis B, caused by related bacteria, might cause some cross-immunity to gonorrhoea.

If the vaccine is just a little bit different to the target virus, it is not expected to offer much protection,» said principal investigator of the study Jeffery Taubenberger, MD, PhD, Chief of Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID).

Poor countries will get little if any vaccine

This means by the time we have vaccines ready to be tested, there may not be enough cases of Zika in the community to test if the vaccine works.»

If a vaccine sensitises them to internal flu proteins, they could potentially kill all types of flu.

However, it will take several years to determine if the vaccine works, Dr. D'Orso said.

«If the vaccine behaves like this in people, it would limit lesions to appearing only about one day in 100, and the virus would be potentially contagious only about two in every 1,000 days,» Friedman said.

Then came the what ifs: What if a vaccine produced just antibodies to the stem?

The company is starting larger trials to see if the vaccine can actually protect people from getting sick.

The mRNA vaccine approach has other advantages, Weissman added: «If a vaccine is effective after just a single immunization, the infrastructure needed for its administration can be much simpler.

If a vaccine is to protect the intestines and other mucous membranes in the body, it also needs to be given through the mucosa, for example as a nasal spray or a liquid that is drunk.

The mucosa forms a unique immunological antibody memory that does not occur if the vaccine is given by injection.

If the vaccine also proves safe and effective in subsequent tests in humans, it might be possible to mount a containment strategy similar to that used in the past against smallpox.

The implication is that if a vaccine enters the fight against HIV, its contribution doesn't have to be a knockout blow.

«If this vaccine is used correctly, many people could be spared illness and hospitalization from dengue.

Aylward will ask the WHO to approve replacing tOPV in poor countries with bOPV, possibly next year, if a vaccine - derived outbreak in Africa is controlled.

Given current vaccination rates, Gillison says, she is not optimistic it will make much difference «even if the vaccine works.»

However, even if a vaccine were available today, many of the world's poorest people would not be able to receive it due to political and economic concerns surrounding vaccine injuries.

It would be most inappropriate if the vaccine stayed unused in a warehouse somewhere or if it were used for ridiculous targets.

Even if the vaccine works only in Latin America, it will still be a «significant improvement over what we have now», says Howard Engers, head of malaria immunology at the WHO.

If the vaccine is not a good match for the virus — as is the case with the H5N1 strain now sweeping Asia — it can still replicate but most animals do not show signs of disease.

The vaccine may protect people from the current H5N1 flu, but no one knows if the vaccine will work if the virus evolves to allow person - to - person transmission.

Further study will be needed to see if this vaccine could potentially be approved to treat recurrent brain tumors.

But, he argues, at least the company's commercial interest is in line with society's need to find out if the vaccine works.

But they will have to give a Zika - vaccinated animal dengue to see if the vaccine makes that illness worse.

No one knows if that vaccine can produce nasal memory T cells.